Dr Chelsea Chapkin Albanese, DO | |
15340 S Jog Rd Ste 200, Delray Beach, FL 33446-2170 | |
(561) 496-7200 | |
Not Available |
Full Name | Dr Chelsea Chapkin Albanese |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 10 Years |
Location | 15340 S Jog Rd Ste 200, Delray Beach, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003288838 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OS14329 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Specialists Of The Palm Beaches Inc | 0244143758 | 110 |
News Archive
After five years of reviewing the latest research findings, a panel of experts led by a Duke University Medical Center anesthesiologist has developed new guidelines to help physicians reduce the occurrence of nausea and vomiting in patients after surgery.
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
› Verified 6 days ago
Entity Name | Medical Specialists Of The Palm Beaches Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386687580 PECOS PAC ID: 0244143758 Enrollment ID: O20031111000205 |
News Archive
After five years of reviewing the latest research findings, a panel of experts led by a Duke University Medical Center anesthesiologist has developed new guidelines to help physicians reduce the occurrence of nausea and vomiting in patients after surgery.
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
› Verified 6 days ago
Entity Name | Cohen Medical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033160908 PECOS PAC ID: 4981600632 Enrollment ID: O20061020000026 |
News Archive
After five years of reviewing the latest research findings, a panel of experts led by a Duke University Medical Center anesthesiologist has developed new guidelines to help physicians reduce the occurrence of nausea and vomiting in patients after surgery.
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Chelsea Chapkin Albanese, DO 7593 W Boynton Beach Blvd Ste 220, Boynton Beach, FL 33437-6162 Ph: (561) 678-2652 | Dr Chelsea Chapkin Albanese, DO 15340 S Jog Rd Ste 200, Delray Beach, FL 33446-2170 Ph: (561) 496-7200 |
News Archive
After five years of reviewing the latest research findings, a panel of experts led by a Duke University Medical Center anesthesiologist has developed new guidelines to help physicians reduce the occurrence of nausea and vomiting in patients after surgery.
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
› Verified 6 days ago
Dr. Alvin Gordon Beyerlein Jr., MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 15300 S Jog Rd Ste 205, Delray Beach, FL 33446 Phone: 561-493-7200 Fax: 561-496-7989 | |
Dr. Ahmet H Lavkan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4662 Hammock Cir, Delray Beach, FL 33445 Phone: 561-254-6464 | |
Marlon Amos Labi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13593 Barcelona Lake Cir, Delray Beach, FL 33446 Phone: 954-849-4953 | |
John Receveur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2932 Sw 22nd Cir Apt B, Delray Beach, FL 33445 Phone: 302-507-4975 | |
Rodolfo Reyes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N Congress Ave Ste 403, Delray Beach, FL 33445 Phone: 561-272-1618 Fax: 561-272-2880 | |
Marie Rubby Roger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13455 S Military Trl Ste A, Delray Beach, FL 33484 Phone: 561-288-6153 Fax: 561-288-6087 |